The overall prevalence of anti-HCV antibody in a group of 125 haemophiliacs was 62%. Four patients who had never received replacement therapy were anti-HCV negative. Of the 121 patients injected regularly with commercial concentrates, 76 were already anti-HCV seropositive in 1985 and remained so throughout the follow-up. Two patients seroconverted in 1987 without obvious signs or symptoms of hepatitis. Our patients were treated with dry heat-treated concentrates since 1985 and with wet heat- or solvent/detergent-treated concentrates since 1988. The absence of further seroconversions and of symptoms of acute post-transfusion non-A, non-B hepatitis since 1988 suggest that present virucidal treatments of concentrates are effective in preventing HCV transmission. Anti-HCV positivity appeared to be unrelated to the type and degree of haemophilia as well as to the presence of antibodies to hepatitis B virus, human immunodeficiency virus type 1, and human herpesvirus type 6.
|Autori interni:||PISTELLO, MAURO|
|Autori:||Pistello M.; Ceccherini Nelli L; Cecconi N.; Bendinelli M.; Panicucci F.|
|Titolo:||Hepatitis C virus seroprevalence in italian hemophiliacs injected with virus-inactivated concentrates: five years follow-up and correlation with antibodies to other viruses.|
|Anno del prodotto:||1991|
|Digital Object Identifier (DOI):||10.1002/jmv.1890330109|
|Appare nelle tipologie:||1.1 Articolo in rivista|